Vivici Secures US Production for Precision-Fermented Dairy Protein via Liberation Labs Deal
Vivici, a Dutch precision fermentation company, has secured a manufacturing partnership with US-based Liberation Labs for the production of its beta-lactoglobulin (BLG) protein ingredient, Vivitein™. The agreement will see Vivici’s product manufactured at Liberation Labs’ new facility in Richmond, Indiana, with commercial-scale output expected to begin in 2026. The Richmond site is Liberation Labs’ first commercial-scale biomanufacturing facility, currently under construction. It will feature 600,000 liters of fermentation capacity and a fully integrated downstream process. The company plans to use this infrastructure to produce a variety of bio-based materials, including proteins, chemicals, and ingredients for consumer and industrial applications. Expansion into the US market Vivici’s CEO, Stephan van Sint Fiet, stated that the partnership would expand the company’s manufacturing footprint beyond Europe and help meet …